Showing 9981-9990 of 18064 results for "".
- Exploring the Prognostic Role of Inflammation-Related Genes in Lung Adenocarcinomahttps://reachmd.com/news/exploring-the-prognostic-role-of-inflammation-related-genes-in-lung-adenocarcinoma/2471519/Recent advances in genetic profiling have illuminated the pivotal role of inflammation-related genes in determining the prognosis of lung adenocarcinoma. There is a growing emphasis on integrating precise biomarkers into clinical decision-making
- Revolutionizing Lung Cancer Detection: The Promise of Hybrid Molecular Imaginghttps://reachmd.com/news/revolutionizing-lung-cancer-detection-the-promise-of-hybrid-molecular-imaging/2471520/Overview and Clinical Relevance The novel hybrid molecular imaging test employs targeted antibodies combined with a radioisotope to specifically identify lung cancer cells. This breakthrough method promises to overcome the sensitivity and specificity chall
- ICONIC-LEAD: Icotrokinra Clears Almost Half of Psoriasis Patients in Phase 3 Trialhttps://reachmd.com/news/iconic-lead-icotrokinra-clears-almost-half-of-psoriasis-patients-in-phase-3-trial/2471543/Nearly half of patients with moderate-to-severe plaque psoriasis treated with icotrokinra achieved completely clear skin at week 24, according to new data presented at the 2025 America Academy of Dermatology Annual Meeting. The
- Global Rise in Postmenopausal Osteoarthritis: Unraveling Trends and Impactshttps://reachmd.com/news/global-rise-in-postmenopausal-osteoarthritis-unraveling-trends-and-impacts/2471432/Recent global studies reveal a dramatic over 130% increase in osteoarthritis cases among postmenopausal women, emphasizing the role of hormonal changes in joint degeneration and the resulting rise in associated disabilities. The evolving landsca
- Exploring Hysteroscopic Niche Resection: Anatomical Insights and Symptom Reliefhttps://reachmd.com/news/exploring-hysteroscopic-niche-resection-anatomical-insights-and-symptom-relief/2471422/Hysteroscopic niche resection (HNR) is emerging as a promising treatment for women suffering from postmenstrual spotting. Recent evidence highlights significant anatomical improvements—most notably, an increase in residual myometrial thickness along with a reduction in nich
- Topical Gel Bimiralisib Shows Promise for AK in Interim Resultshttps://reachmd.com/news/Topical-Gel-Bimiralisib-Shows-Promise-AK-Interim-Results/2471537/Interim results from an ongoing Phase 2 clinical trial in actinic keratosis highlighted strong potential for the safety and efficacy of topical gel bimiralisib, a selective pan-PI3K/mTOR inhibitor, Torqur AG announced at the 2025 American Academy of Dermatology (AAD) Annual Meeting in Orlando, Fl
- Exploring the Link Between Iron Dysregulation and Long COVIDhttps://reachmd.com/news/exploring-the-link-between-iron-dysregulation-and-long-covid/2471515/In the wake of the COVID-19 pandemic, emerging research has begun to shed light on a possible mechanism behind long-term complications known as Long COVID. Disruptions in iron regulation following SARS-CoV-2 infection may be a critical factor driving persistent symptoms.
- JAK Inhibitors, Low-Dose Naltrexone Touted as New Options for Nail Lichen Planushttps://reachmd.com/news/JAK-Inhibitors-Low-Dose-Naltrexone-Touted-New-Options-Nail-Lichen-Planus/2471532/JAK inhibitors and low-dose naltrexone appear to be two game-changing options for treatment of nail lichen planus, Shari Lipner, MD, PhD, FAAD, said at the 2025 American Academy of Dermatology (AAD) Annual Meeting in Orlando, Florida. Dr. Lipner noted the activity of the JAK pathway in lic
- JAK Inhibitors' Applications Continue to Expandhttps://reachmd.com/news/JAK-Inhibitors-Applications-Continue-Expand/2471523/While JAK inhibitors have become widely popular for several common skin diseases, their potential for other indications remains vast, and Ruth Ann Vleugels, MD, MPA, MPH, FAAD, highlighted some of these in “JAK Inhibitors for Lupus, Dermatomyositis, and SAVI” at the 2025 American Academy of Derma
- Unraveling Genetic Factors in ACE Inhibitor-Induced Angioedema: Insights from Whole Exome Sequencinghttps://reachmd.com/news/unraveling-genetic-factors-in-ace-inhibitor-induced-angioedema-insights-from-whole-exome-sequencing/2471436/The application of whole exome sequencing has revealed that the F5 gene variant rs6025 may significantly elevate the risk of angioedema in patients prescribed ACE inhibitors. This discovery is pivotal not only for its immediate impact on patient management but also